Omeros Corp: Of Form 8k, This Filing Is Being Made To Report That At December 31, 2025,we Had Approximately $171.5 Million Of Cash And Shortterm Investments Available For Operations. This Figure Is Preliminary And Unaudited. It Is Subject To Completion Of The Company’s Customary Financial Closing Procedures And Adjustments

Show full article

This functionality is available for registred users only

• Full name
  Omeros Corporation
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***